Skip to main content
Erschienen in: Supportive Care in Cancer 7/2011

01.07.2011 | Original Article

Sleep in children with cancer: case review of 70 children evaluated in a comprehensive pediatric sleep center

verfasst von: Gerald Rosen, Sarah R. Brand

Erschienen in: Supportive Care in Cancer | Ausgabe 7/2011

Einloggen, um Zugang zu erhalten

Abstract

Goal

The goal of this study was to characterize the sleep problems of children with cancer who were referred for a comprehensive sleep evaluation.

Materials and methods

A retrospective case series review was conducted of all children with cancer referred to the pediatric sleep clinic from 1994 to 2009 for evaluation of a sleep problem. Seventy children were seen and evaluated during this interval; all had a complete sleep history taken, and further objective sleep evaluations were performed as part of their evaluation only when clinically indicated. An overnight polysomnogram was performed in 53 children. In 36 children with a history of excessive daytime sleepiness (EDS), a multiple sleep latency study was performed the following day. Seven children had a 3–4-week actigraphic study.

Results

Children with neoplasms of central nervous system (CNS) involving the hypothalamus, thalamus, and brainstem were the most commonly referred children and had the most frequent and severe sleep problems. Excessive daytime sleepiness was the most common sleep problem, seen in 60% of children with cancer and in 80% of children with CNS neoplasms involving the hypothalamus, thalamus, and brainstem. Sleep disordered breathing (SDB) was present in 40% of the entire group of children with cancer and 46% of children with neoplasms involving the hypothalamus, thalamus, and brainstem. Children with CNS neoplasms often had more than one sleep problem, most commonly EDS and SDB. In these children, correction of the SDB often did not eliminate the EDS. In children with leukemia, insomnia was the most common sleep problem identified, present in 39%. The causes of the sleep problems were varied and included neurologic injury caused by the neoplasm and/or the CNS-directed treatments; seizures, adenotonsillar hypertrophy, medication side effects, obesity, pain, anxiety, and drug abuse. Some of the sleep problems were present before the diagnosis of cancer, though most developed after treatment was begun. A wide range of intervention strategies were utilized to address the sleep problems and included sleep hygiene/sleep restriction, behavioral counseling, continuous positive airway pressure, bilevel positive airway pressure, tracheotomy with and without a ventilator, diaphragmatic pacers, sedative hypnotics, stimulants, anticonvulsants, and antidepressants. When the sleep problems and their causes were correctly identified and treatments were directed to the specific cause of the problem, the treatments were generally successful.

Conclusions

The sleep problems of children with cancer span the full spectrum of clinical sleep disorders (hypersomnia, sleep disordered breathing, insomnia, parasomnias, and circadian rhythm disorders) and are often present in combinations. Children with neoplasms involving the brainstem, thalamus, and hypothalamus were the most frequently referred for a sleep evaluation, and their sleep problems were most commonly EDS or SDB. Expertise in pediatric sleep disorders can be a valuable resource in the ongoing care of children with cancer.
Literatur
1.
Zurück zum Zitat Saper C, Scammell T, Lu J (2005) Hypothalamic regulation of sleep and circadian rhythms. Nature 437:1257–1263PubMedCrossRef Saper C, Scammell T, Lu J (2005) Hypothalamic regulation of sleep and circadian rhythms. Nature 437:1257–1263PubMedCrossRef
2.
Zurück zum Zitat Muller H, Handwerker G, Gebhardt U et al (2007) Melatonin treatment in obese patients with craniopharyngioma and increased sleepiness. Cancer Causes Control 17:583–589CrossRef Muller H, Handwerker G, Gebhardt U et al (2007) Melatonin treatment in obese patients with craniopharyngioma and increased sleepiness. Cancer Causes Control 17:583–589CrossRef
3.
Zurück zum Zitat Puget S, Garnett M, Wray A et al (2007) Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg Pediatr 106:3–12CrossRef Puget S, Garnett M, Wray A et al (2007) Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg Pediatr 106:3–12CrossRef
4.
Zurück zum Zitat Benesch M, Lackner H, Sovinz P et al (2006) Late sequela after treatment of childhood low-grade gliomas: a retrospective analysis of 69 long term survivors treated between 1983 and 2003. J Neuro-oncol 78:199–205CrossRef Benesch M, Lackner H, Sovinz P et al (2006) Late sequela after treatment of childhood low-grade gliomas: a retrospective analysis of 69 long term survivors treated between 1983 and 2003. J Neuro-oncol 78:199–205CrossRef
5.
Zurück zum Zitat Wilne S, Collier J, Kennedy C et al (2007) Presentation of childhood CNS tumors: a systematic review and meta-analysis. Lancet Oncol 8:685–695PubMedCrossRef Wilne S, Collier J, Kennedy C et al (2007) Presentation of childhood CNS tumors: a systematic review and meta-analysis. Lancet Oncol 8:685–695PubMedCrossRef
6.
Zurück zum Zitat Rosen GM, Bendel AE, Neglia JP, Moertel CL, Mahowald M (2003) Sleep in children with neoplasms of the central nervous system: case review of 14 children. Pediatrics 112(1):e46–e54PubMedCrossRef Rosen GM, Bendel AE, Neglia JP, Moertel CL, Mahowald M (2003) Sleep in children with neoplasms of the central nervous system: case review of 14 children. Pediatrics 112(1):e46–e54PubMedCrossRef
7.
Zurück zum Zitat Nishino S, Kanbayashi T (2005) Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev 9:269–310PubMedCrossRef Nishino S, Kanbayashi T (2005) Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev 9:269–310PubMedCrossRef
8.
Zurück zum Zitat Palm L, Nordin V, Elmquist D et al (1992) Sleep and wakefulness after treatment for craniopharyngioma in childhood; influence on the quality and maturation of sleep. Neuropediatrics 23:39–45PubMedCrossRef Palm L, Nordin V, Elmquist D et al (1992) Sleep and wakefulness after treatment for craniopharyngioma in childhood; influence on the quality and maturation of sleep. Neuropediatrics 23:39–45PubMedCrossRef
9.
Zurück zum Zitat Someren E, Swart-Heikens J, Endert E et al (2004) Long term effect of cranial irradiation for childhood malignancy on sleep in adulthood. European J Endo 150:503–510CrossRef Someren E, Swart-Heikens J, Endert E et al (2004) Long term effect of cranial irradiation for childhood malignancy on sleep in adulthood. European J Endo 150:503–510CrossRef
10.
Zurück zum Zitat Ryan J (2000) Radiation somnolence syndrome. J Pediatr Oncol Nurs 17:50–53PubMed Ryan J (2000) Radiation somnolence syndrome. J Pediatr Oncol Nurs 17:50–53PubMed
11.
Zurück zum Zitat Faithful S, Brada M (1998) Somnolence syndrome in adults following cranial irradiation for primary brain tumors. Clin Oncol 10:250–254CrossRef Faithful S, Brada M (1998) Somnolence syndrome in adults following cranial irradiation for primary brain tumors. Clin Oncol 10:250–254CrossRef
12.
Zurück zum Zitat Mindell J, Owens J (2003) A clinical guide to pediatric sleep, diagnosis and management of sleep problems. Lippincott, Philadelphia Mindell J, Owens J (2003) A clinical guide to pediatric sleep, diagnosis and management of sleep problems. Lippincott, Philadelphia
13.
Zurück zum Zitat Jenni OG, Carscadon MA (2007) Sleep behavior and sleep regulation from infancy through adolescence: normative aspects. Sleep Med Clin 2:321–329CrossRef Jenni OG, Carscadon MA (2007) Sleep behavior and sleep regulation from infancy through adolescence: normative aspects. Sleep Med Clin 2:321–329CrossRef
14.
Zurück zum Zitat Carscadon MA, Acebo A (2002) Regulation of sleepiness in adolescents: updates, insights, and speculation. Sleep 25(6):606–614 Carscadon MA, Acebo A (2002) Regulation of sleepiness in adolescents: updates, insights, and speculation. Sleep 25(6):606–614
15.
Zurück zum Zitat Iglowstein I, Jenni O, Molinari L et al (2003) Sleep duration from infancy to adolescence: reference values and generational trends. Pediatrics 111:302–307PubMedCrossRef Iglowstein I, Jenni O, Molinari L et al (2003) Sleep duration from infancy to adolescence: reference values and generational trends. Pediatrics 111:302–307PubMedCrossRef
16.
Zurück zum Zitat Mindell J, Kuhn B, Lewin D et al (2006) Behavioral treatments of bedtime problems and night wakings in infants and young children. Sleep 29(10):1263–1276PubMed Mindell J, Kuhn B, Lewin D et al (2006) Behavioral treatments of bedtime problems and night wakings in infants and young children. Sleep 29(10):1263–1276PubMed
17.
Zurück zum Zitat Owens J (2005) In: Sheldon S, Ferber R, Kryger M (eds) Principles and practice of pediatric sleep medicine. Elsevier, Philadelphia, pp 27–34CrossRef Owens J (2005) In: Sheldon S, Ferber R, Kryger M (eds) Principles and practice of pediatric sleep medicine. Elsevier, Philadelphia, pp 27–34CrossRef
18.
Zurück zum Zitat Brooks L (2005) Obstructive sleep apnea syndrome in infants and children: clinical features and pathophysiology. In: Sheldon S, Ferber R, Kryger M (eds) Principles and practice of pediatric sleep medicine. Elsevier, Philadelphia, pp 223–231 Brooks L (2005) Obstructive sleep apnea syndrome in infants and children: clinical features and pathophysiology. In: Sheldon S, Ferber R, Kryger M (eds) Principles and practice of pediatric sleep medicine. Elsevier, Philadelphia, pp 223–231
19.
Zurück zum Zitat Rosen G (2005) Evaluation of the patient who has sleep complaints: a case based method using the sleep process matrix. Prim Care Clin Office Pract 32:319–328CrossRef Rosen G (2005) Evaluation of the patient who has sleep complaints: a case based method using the sleep process matrix. Prim Care Clin Office Pract 32:319–328CrossRef
21.
Zurück zum Zitat CBTRUS Central (2005) Statistical report: primary brain tumors in the United States, 1998–2002. Central Brain Tumor Registry of the United States, Hinsdale CBTRUS Central (2005) Statistical report: primary brain tumors in the United States, 1998–2002. Central Brain Tumor Registry of the United States, Hinsdale
22.
Zurück zum Zitat Oeffinger K, Mertens A, Sklar C et al (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355(15):1572–1582PubMedCrossRef Oeffinger K, Mertens A, Sklar C et al (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355(15):1572–1582PubMedCrossRef
23.
Zurück zum Zitat Gurney JG, Kadan-Lottick NS, Packer RJ et al (2003) Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors. Childhood Cancer Survivor Study. Cancer 97(3):663–673PubMedCrossRef Gurney JG, Kadan-Lottick NS, Packer RJ et al (2003) Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors. Childhood Cancer Survivor Study. Cancer 97(3):663–673PubMedCrossRef
24.
Zurück zum Zitat Mulhern RK, Merchant TE, Wallace D, Kocak M, Brouwers P, Krull K, Chintagumpala M, Stargatt R, Ashley DM, Tyc VL, Kun L, Boyett J, Gajjar A (2005) Neurocognitive consequences of risk adapted therapy for childhood medulloblastoma. J Clin Oncol 23(24):5511–5519PubMedCrossRef Mulhern RK, Merchant TE, Wallace D, Kocak M, Brouwers P, Krull K, Chintagumpala M, Stargatt R, Ashley DM, Tyc VL, Kun L, Boyett J, Gajjar A (2005) Neurocognitive consequences of risk adapted therapy for childhood medulloblastoma. J Clin Oncol 23(24):5511–5519PubMedCrossRef
25.
Zurück zum Zitat Ancoli-Israel A, Moore P, Jones V (2001) The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care 10:245–255CrossRef Ancoli-Israel A, Moore P, Jones V (2001) The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care 10:245–255CrossRef
26.
Zurück zum Zitat Iber C, Ancoli-Israel S, Chesson A, Quan S (2007) The AASM manual for the scoring of sleep and associated disorders. AASM, Westchester Iber C, Ancoli-Israel S, Chesson A, Quan S (2007) The AASM manual for the scoring of sleep and associated disorders. AASM, Westchester
27.
Zurück zum Zitat Hauri P, Sateia M (2005) The international classification of sleep disorders diagnostic and coding manual, 2nd edn. AASM, Westchester Hauri P, Sateia M (2005) The international classification of sleep disorders diagnostic and coding manual, 2nd edn. AASM, Westchester
28.
Zurück zum Zitat Littner M, Kushida C, Anderson W et al (2003) Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. Sleep 26:337–341PubMed Littner M, Kushida C, Anderson W et al (2003) Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. Sleep 26:337–341PubMed
29.
Zurück zum Zitat Littner M, Kushida C, Wise M et al (2005) Practice parameters in the clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 28:113–121PubMed Littner M, Kushida C, Wise M et al (2005) Practice parameters in the clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 28:113–121PubMed
30.
Zurück zum Zitat Hinds P, Hockenberry M, Gattuso J et al (2007) Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia. Cancer 110:2321–2330PubMedCrossRef Hinds P, Hockenberry M, Gattuso J et al (2007) Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia. Cancer 110:2321–2330PubMedCrossRef
31.
Zurück zum Zitat Savard J, Liu L, Natarajan L, Rissling MB, Neikrug AB, He F, Dimsdale JE, Mills PJ, Parker BA, Sadler GR, Ancoli-Israel S (2009) Breast cancer patients have progressively impaired sleep–wake activity rhythms during chemotherapy. Sleep 32:1155–1160PubMed Savard J, Liu L, Natarajan L, Rissling MB, Neikrug AB, He F, Dimsdale JE, Mills PJ, Parker BA, Sadler GR, Ancoli-Israel S (2009) Breast cancer patients have progressively impaired sleep–wake activity rhythms during chemotherapy. Sleep 32:1155–1160PubMed
32.
Zurück zum Zitat Dupuis L, Milne-Wren C, Cassidy M et al (2010) Symptom assessment in children receiving cancer therapy: the parents perspective. Support Care Cancer 18:281–299PubMedCrossRef Dupuis L, Milne-Wren C, Cassidy M et al (2010) Symptom assessment in children receiving cancer therapy: the parents perspective. Support Care Cancer 18:281–299PubMedCrossRef
33.
Zurück zum Zitat Meeske K, Katz E, Palmer S et al (2004) Parent proxy-reported health related quality of life and fatigue in pediatric patients diagnosed with brain tumors and acute lymphoblastic leukemia. Cancer 101:2116–2125PubMedCrossRef Meeske K, Katz E, Palmer S et al (2004) Parent proxy-reported health related quality of life and fatigue in pediatric patients diagnosed with brain tumors and acute lymphoblastic leukemia. Cancer 101:2116–2125PubMedCrossRef
Metadaten
Titel
Sleep in children with cancer: case review of 70 children evaluated in a comprehensive pediatric sleep center
verfasst von
Gerald Rosen
Sarah R. Brand
Publikationsdatum
01.07.2011
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 7/2011
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-010-0921-y

Weitere Artikel der Ausgabe 7/2011

Supportive Care in Cancer 7/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.